Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial

de Yebenes, Justo Garcia, Landwehrmeyer, Bernhard, Squitieri, Ferdinando, Reilmann, Ralf, Rosser, Anne Elizabeth ORCID: https://orcid.org/0000-0002-4716-4753, Barker, Roger, Saft, Carsten, Magnet, Markus, Sword, Alastair, Rembratt, Åsa and Tedroff, Joakim 2011. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Neurology 10 (12) , pp. 1049-1057. 10.1016/S1474-4422(11)70233-2

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Publisher:	Elsevier
ISSN:	1474-4422
Last Modified:	19 Oct 2022 09:38
URI:	https://orca.cardiff.ac.uk/id/eprint/21729

Actions (repository staff only)

Edit Item